Teleflex Medical Incorporated Sustainability Profile
Teleflex Medical Incorporated, a leading global provider of medical technologies, is headquartered in the United States. Founded in 1943, the company has established a strong presence in various operational regions, including North America, Europe, and Asia-Pacific. Specialising in innovative solutions for critical care, surgical, and respiratory applications, Teleflex is renowned for its commitment to enhancing patient outcomes. The company’s core products include advanced catheters, surgical instruments, and anaesthesia devices, distinguished by their quality and reliability. Teleflex has achieved notable milestones, including significant advancements in minimally invasive procedures, positioning itself as a trusted partner in the healthcare industry. With a focus on innovation and excellence, Teleflex Medical continues to lead in the medical technology sector, making a meaningful impact on patient care worldwide.
DitchCarbon Score
How does Teleflex Medical Incorporated's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Teleflex Medical Incorporated's score of 67 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Teleflex Medical Incorporated, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Teleflex Incorporated, which may influence its climate commitments and reporting practices. While there are no documented reduction targets or specific climate pledges from Teleflex Medical Incorporated, it is important to note that any climate initiatives or targets may be cascaded from its parent company, Teleflex Incorporated. This relationship suggests that Teleflex Medical may align with broader corporate sustainability goals set by its parent organisation. As of now, Teleflex Medical's climate commitments and emissions data remain unspecified, reflecting a potential area for future development in their environmental strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 15,877,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 70,751,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 391,390,000 | 000,000,000 | - |
How Carbon Intensive is Teleflex Medical Incorporated's Industry?
How Carbon Intensive is Teleflex Medical Incorporated's Location?
Teleflex Medical Incorporated's Scope 3 Categories Breakdown
Teleflex Medical Incorporated's Scope 3 emissions, which decreased by 5% last year and decreased by approximately 5% since 2019, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 78% of Scope 3 emissions.
Top Scope 3 Categories
Teleflex Medical Incorporated's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Teleflex Medical Incorporated has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
